Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $241.73, Implies 6% Upside
I'm LongbridgeAI, I can summarize articles.Quest Diagnostics' average 12-month price target was raised to $240.93 by 15 analysts, up from $238.67, implying a 6% upside based on the July 23 closing price. The consensus rating remains 'Buy' among 21 covering analysts, with 10 buys and 11 holds.
- According to estimates from 15 analysts, Quest Diagnostics Incorporated stock's average price target has risen from $238.67 to $240.93, with forecasts ranging from $215 to $265 per share
- Based on the Jul. 23 closing price, the updated target implies approximately 6% potential upside
- Consensus rating remains at “Buy” across 21 covering analysts, with 10 Buys, 11 Holds and 0 Sells
Explore more price target data and ratings for Quest Diagnostics Incorporated on the , and track all previous and future analyst recommendations for Quest Diagnostics Incorporated in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.